[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Pages 56964-56965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20088]



Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.


SUMMARY: As required by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting. 
The meeting will be open to the public via webcast. For this meeting, 
the TBDWG will review and vote upon the

[[Page 56965]]

third and final Report to Congress and the HHS Secretary. The 2022 
report will address a wide range of topics related to tick-borne 
diseases, such as, surveillance, prevention, diagnosis, diagnostics, 
and treatment; identify advances made in research, as well as overlap 
and gaps in tick-borne disease research; and provide recommendations 
regarding any appropriate changes or improvements to such activities 
and research.

DATES: The public can view the meeting online via webcast on October 
25, 2022 from approximately 9:00 a.m. to 5:00 p.m. ET (times are 
tentative and subject to change) each day. The confirmed times and 
agenda items for the meeting will be posted on the TBDWG web page at 
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-25/index.html when this information becomes available.

FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal 
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS 
Policy, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, Tower Building, 1101 Wootton Parkway, 
Rockville, MD 20852. Email: [email protected]. Phone: 202-795-

SUPPLEMENTARY INFORMATION: A link to view the webcast can be found on 
the meeting website at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-25/index.html when it becomes 
available. The public will have an opportunity to present their views 
to the TBDWG orally during the meeting's public comment session or by 
submitting a written public comment. Comments should be pertinent to 
the meeting discussion. Persons who wish to provide verbal or written 
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-25/index.html and 
respond by midnight October 17, 2022 ET. Verbal comments will be 
limited to three minutes each to accommodate as many speakers as 
possible during the 30-minute session. Written public comments will be 
accessible to the public on the TBDWG web page prior to the meeting.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. app., as amended, to provide expertise and review federal 
efforts related to all tick-borne diseases, to help ensure interagency 
coordination and minimize overlap, and to examine research priorities. 
The TBDWG is required to submit a report to the HHS Secretary and 
Congress on their findings and any recommendations for the federal 
response to tick-borne disease every two years.

    Dated: September 8, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of 
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2022-20088 Filed 9-15-22; 8:45 am]